Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Authors: Riedl, J.M. ^{1, 2, †}, Fece de la Cruz, F. ^{1, †}, Lin, J.J. ¹, Parseghian, C. ², Kim, J.E. ^{1, 3}, Matsubara, H. ¹, Barnes, H. ¹, Caughey, B. ¹, Norden, B.L. ¹, Morales-Giron, A.A. ¹, Kushner, E.W. ¹, Ehnstrom, S. ¹, Nakamura, H. ¹, Patel, P.S. ¹, Ellis, H. ¹, Pappas, L. ¹, Vakaris, A. ¹, Gainor, J.F. ¹, Kopetz, S. ², Klempner, S.J. ¹, Parikh, A.R. ¹, Hata, A.N. ¹, Heist, R.S. ¹, Corcoran, R.B. ^{1, ∗}

Source: In Annals of Oncology

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Authors: André, T., Lonardi, S., Wong, K.Y.M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M.A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M.B., Hendlisz, A., Neyns, B., Abdullaev, S., Memaj, A., Lei, M., Dixon, M., Kopetz, S., Overman, M.J.

Source: In Annals of Oncology October 2022 33(10):1052-1060

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC

Authors: Kopetz, S., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y.S., Steeghs, N., Guren, T.K., Arkenau, H.-T., Garcia-Alfonso, P., Belani, A., Zhang, X., Tabernero, J.

Source: In ESMO Open June 2022 7(3)

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study

Authors: Tabernero, J., Velez, L., Trevino, T.L., Grothey, A., Yaeger, R., Van Cutsem, E., Wasan, H., Desai, J., Ciardiello, F., Yoshino, T., Gollerkeri, A., Maharry, K., Christy-Bittel, J., Kopetz, S.

Source: In ESMO Open December 2021 6(6)

Electrical-Optical Circuit Board using Polysiloxane Optical Waveguide Layer

Authors: Neyer, A., Kopetz, S., Rabe, E., Kang, W.J., Tombrink, S.

Source: Proceedings Electronic Components and Technology, 2005. ECTC '05. Electronic components and technology Electronic Components and Technology Conference, 2005. Proceedings. 55th. :246-250 2005

Relation: 2005 Proceedings. 55th Electronic Components and Technology Conference

How liquid biopsies can change clinical practice in oncology

Authors: Siravegna, G., Mussolin, B., Venesio, T., Marsoni, S., Seoane, J., Dive, C., Papadopoulos, N., Kopetz, S., Corcoran, R.B., Siu, L.L., Bardelli, A. ^*

Source: In Annals of Oncology October 2019 30(10):1580-1590

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Authors: Parseghian, C.M. ^*, Loree, J.M., Morris, V.K., Liu, X., Clifton, K.K., Napolitano, S., Henry, J.T., Pereira, A.A., Vilar, E., Johnson, B., Kee, B., Raghav, K., Dasari, A., Wu, J., Garg, N., Raymond, V.M., Banks, K.C., Talasaz, A.A., Lanman, R.B., Strickler, J.H., Hong, D.S., Corcoran, R.B., Overman, M.J., Kopetz, S.

Source: In Annals of Oncology February 2019 30(2):243-249

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2

Authors: Chang, K., Willis, J.A., Reumers, J., Taggart, M.W., San Lucas, F.A., Thirumurthi, S., Kanth, P., Delker, D.A., Hagedorn, C.H., Lynch, P.M., Ellis, L.M., Hawk, E.T., Scheet, P.A., Kopetz, S., Arts, J., Guinney, J., Dienstmann, R. ^*, Vilar, E. ^*

Source: In Annals of Oncology October 2018 29(10):2061-2067

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Authors: Yoshino, T. ^*, Arnold, D., Taniguchi, H., Pentheroudakis, G., Yamazaki, K., Xu, R.-H., Kim, T.W., Ismail, F., Tan, I.B., Yeh, K.-H., Grothey, A., Zhang, S., Ahn, J.B., Mastura, M.Y., Chong, D., Chen, L.-T., Kopetz, S., Eguchi-Nakajima, T., Ebi, H., Ohtsu, A., Cervantes, A., Muro, K., Tabernero, J., Minami, H., Ciardiello, F., Douillard, J.-Y.

Source: In Annals of Oncology January 2018 29(1):44-70

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

Authors: Overman, M.J. ^*, Adam, L., Raghav, K., Wang, J., Kee, B., Fogelman, D., Eng, C., Vilar, E., Shroff, R., Dasari, A., Wolff, R., Morris, J., Karunasena, E., Pisanic, R., II, Azad, N., Kopetz, S.

Source: In Annals of Oncology January 2018 29(1):139-144

Defining the subset of mutations in polymerase epsilon (POLE) associated with loss-of-proofreading (LOP) functionality

Authors: Maddalena, G., Zeineddine, F.A., Rivero-Hinojosa, S., Aushev, V.N., Chowdhury, S., Zeineddine, M.A., Yousef, A.M., Yap, T.A., EINaggar, A.C., Liu, M.C., White, M., Overman, M.J., Kopetz, S., Shen, J.P.

Source: In Annals of Oncology July 2024 35(7):678-680

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E—Mutated Colorectal Cancer

Authors: Kopetz, S.

Source: New England journal of medicine. 381(17):1632-1643

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621946004&indx=1&recIds=ETOCRN621946004

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Authors: Capasso, A., Lang, J., Pitts, T., Jordan, K., Lieu, C., Davis, S., Diamond, J., Kopetz, S., Barbee, J., Peterson, J., Freed, B., Yacob, B., Bagby, S., Messersmith, W., Slansky, J., Pelanda, R., Eckhardt, S.

Source: Journal for immunotherapy of cancer. 7(1):1-16

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186496897.0x000001&indx=1&recIds=ETOCvdc_100186496897.0x000001

Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

Authors: Batth, I.S., Mitra, A., Manier, S., Ghobrial, I.M., Menter, D., Kopetz, S., Li, S. ^*

Source: In Annals of Oncology March 2017 28(3):468-477

Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

Authors: Overman, M.J. ^*, Morris, V., Kee, B., Fogelman, D., Xiao, L., Eng, C., Dasari, A., Shroff, R., Mazard, T., Shaw, K., Vilar, E., Raghav, K., Shureiqi, I., Liang, L., Mills, G.B., Wolff, R.A., Hamilton, S., Meric-Bernstam, F., Abbruzzese, J., Morris, J., Maru, D., Kopetz, S.

Source: In Annals of Oncology June 2016 27(6):1068-1074

Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol

Authors: Meric-Bernstam, F. ^*, Brusco, L., Daniels, M., Wathoo, C., Bailey, A.M., Strong, L., Shaw, K., Lu, K., Qi, Y., Zhao, H., Lara-Guerra, H., Litton, J., Arun, B., Eterovic, A.K., Aytac, U., Routbort, M., Subbiah, V., Janku, F., Davies, M.A., Kopetz, S., Mendelsohn, J., Mills, G.B., Chen, K.

Source: In Annals of Oncology May 2016 27(5):795-800

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

Authors: Morelli, M.P., Overman, M.J., Dasari, A., Kazmi, S.M.A., Mazard, T., Vilar, E., Morris, V.K., Lee, M.S., Herron, D., Eng, C., Morris, J., Kee, B.K., Janku, F., Deaton, F.L., Garrett, C., Maru, D., Diehl, F., Angenendt, P., Kopetz, S. ^*

Source: In Annals of Oncology April 2015 26(4):731-736

Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status

Authors: Odisio, B. C., Yamashita, S., Huang, S. Y., Harmoush, S., Kopetz, S. E., Ahrar, K., Shin Chun, Y., Conrad, C., Aloia, T. A., Gupta, S.

Source: BRITISH JOURNAL OF SURGERY. 104(6):760-768

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383802694&indx=1&recIds=ETOCRN383802694

Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection

Authors: Odisio, B. C., Yamashita, S., Frota, L., Huang, S. Y., Kopetz, S. E., Ahrar, K., Chun, Y. S., Aloia, T. A., Hicks, M. E., Gupta, S.

Source: JOURNAL OF GASTROINTESTINAL SURGERY. 21(4):628-635

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383483993&indx=1&recIds=ETOCRN383483993

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study

Authors: Gulhati, P., Raghav, K., Shroff, R. T., Varadhachary, G. R., Kopetz, S., Javle, M., Qiao, W., Wang, H., Morris, J., Wolff, R. A.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 123(6):1011-1017

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383451447&indx=1&recIds=ETOCRN383451447